DGAP-Adhoc: Pulsion Medical Systems SE: General Meeting approves domination and profit and loss transfer agreement

        Print
| Source: EQS Group AG
Pulsion Medical Systems SE  / Key word(s): Miscellaneous

14.08.2014 19:29

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Pulsion Medical Systems SE: General Meeting approves domination and profit
and loss transfer agreement

Feldkirchen, 14.08.2014 - The extraordinary general meeting of Pulsion
Medical Systems SE (ISIN: DE0005487904 / WKN 548790, "Pulsion") today
approved the domination and profit and loss transfer agreement dated July
3rd, 2014 between MAQUET Medical Systems AG (an indirect subsidiary of
Getinge AB, Sweden) as the controlling entity and Pulsion Medical Systems
SE as the controlled entity according to sec. 293 para. 1 of the German
Stock Corporation Act ("AktG").

The domination and profit and loss transfer agreement provides for a
guaranteed dividend respectively an annual recurring compensation payment
for the shareholders of Pulsion pursuant to sec. 304 AktG in the gross
amount of 1.02 EUR (0.86 EUR net based on the current taxation) per share
and a cash compensation pursuant to sec. 305 AktG in the amount of 17.03
EUR per share.

The domination and profit and loss transfer agreement will be valid upon
its registration with  the commercial register of Pulsion.


Contact:

Investor Relations
PULSION Medical Systems SE
Ralph Schäfer
Director Legal Affairs 
Tel.: +49 (0)89 / 459914 211 
Fax: +49 (0)89 / 459914 481 
E-mail: schaefer@pulsion.com


14.08.2014 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Pulsion Medical Systems SE
              Hans-  Riedl-  Straße 21
              85622 Feldkirchen
              Germany
Phone:        +49 (0)89 4599 14-0
Fax:          +49 (0)89 4599 14-18
E-mail:       info@pulsion.com
Internet:     www.pulsion.com
ISIN:         DE0005487904
WKN:          548790
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin, Düsseldorf, Hamburg, München, Stuttgart
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------